Has the app lost its appeal?

Oakley, Howard
October 2013
MacUser;Oct2013, Vol. 29 Issue 11, p85
The article focuses on the issue of licensing of apps. Corporate lawyers came up with the idea of licensing the use of an app, under complex and invariably incomprehensible terms. Every year or two, vendors released major updates to their products. So it had been until software vendors switched to selling everything online.


Related Articles

  • LICENSE HIGHLIGHTS.  // License!;Jul2005, Vol. 8 Issue 6, p76 

    Presents data on licenses recently granted in the U.S. as of July 2005. Product; Manufacturer; Agent and licensor.

  • YOUR COUNTER. Clapper, Casey // Aftermarket Business;Mar2007, Vol. 117 Issue 3, p1 

    The article focuses on the license agreements which allow companies to form a solid partnership and business opportunities in the U.S. Some of the unique products are born out of license agreement. It simply brings consumer's awareness to lesser-known products. Through licensing, counterpeople...

  • The effect of technological environment and competitive strategy on licensing decisions. Roy, Matthew H.; Dugal, Sanjiv S. // American Business Review;Jun99, Vol. 17 Issue 2, p112 

    Discusses the effect of technological environment and competitive strategy on licensing decisions. Contradiction to the notion that firms with high differentiation strategy will have low levels of licensing; Results indicating that decision to license products depend not only on competitive...

  • Imports of intangibles and service-related transactions. Liedeker, Michele Mack // China Business Review;Jan/Feb99, Vol. 26 Issue 1, p4 

    Reveals that people conducting imports of intangibles and service-related transactions have had trouble receiving royalty payments in China. Percentage of people who reported experiencing after-the-fact review of technology import contracts; Percentage who have found China's domestic banks...

  • EFFIMUNE SIGNS GLOBAL LICENSE AGREEMENT W/ JANSSEN.  // Worldwide Biotech;Nov2013, Vol. 25 Issue 11, p2 

    The article reports on the global option and license agreement signed by the pharmaceutical company Effimune SAS with Janssen Biotech Inc. It outlines the condition of the agreement in which Effimune will grant Janssen with an exclusive option to create FR104 drug. It also details the components...

  • Indexes ditch exclusive listing rights. Collins, Daniel P. // Futures: News, Analysis & Strategies for Futures, Options & Deri;Jan2005, Vol. 34 Issue 1, p16 

    The article reports that an exclusive agreement between Russell Investment Group and the Chicago Board Options Exchange (CBOE) expires at the end of this year, and Russell announced in November plans to seek multiple exchange listings of index options and is negotiating possible license...

  • D&PL, Syngenta In Biotech Joint Venture.  // Cotton Grower;Sep2004, Vol. 40 Issue 9, p6 

    This article reports that Syngenta and Delta and Pine Land (D&PL) Co. have entered into a long-term agreement to develop and commercialize new biotechnology products for cotton. As part of the agreement, Syngenta will grant licenses to D&PL for its insect resistance traits. In return, D&PL will...

  • A COMPARISON OF THE READABILITY OF FREEWARE LICENSE AGREEMENTS FROM 2003 AND 2008. Hayden, Michael B.; Prichard, Janet J. // Proceedings for the Northeast Region Decision Sciences Institute;2009, p203 

    Online free software is often warranted to be free of spyware. However, applications may collect and transmit data back to developers. Technically such applications may not be considered spyware because data collection is disclosed in an End User License Agreement. However, studies have shown...

  • Technical Talk: In conversation with the forensics.  // License! Europe;Winter2004/2005, p55 

    Presents the first in a new series of articles which examines the technical aspects of deal-making in licensing. Condition of licensing contracts; Ratio on the licensors who do not monitor their royalty arrangements and revenues; Implications on matters defined in the licensing.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics